Gaviscon Extra Strength 160 MG / 105 MG Chewable Tablet
- RxCUI
- 212978
- RxNorm name
- Gaviscon Extra Strength 160 MG / 105 MG Chewable Tablet
- Display name
- Gaviscon Extra Strength 160 MG / 105 MG Chewable Tablet
- Full name
- Gaviscon Extra Strength 160 MG / 105 MG Chewable Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gaviscon Extra Strength | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | Haleon US Holdings LLC | 7f367927-c366-465c-a059-e2cfb337d562 | 2025-06-11 | Warnings | 212978 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7f367927-c366-465c-a059-e2cfb337d562 | Gaviscon Extra Strength 160 MG / 105 MG Chewable Tablet [PSN] · aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet [Gaviscon] [SBD] · Gaviscon Extra Strength (aluminum hydroxide 160 MG / magnesium carbonate 105 MG) Chewable Tablet [SY] | 3 | 17 | Drug Facts | 20250611 |